{
  "data": {
    "broad_sector": "PHARMA",
    "niche_industry": "Specialty Generics & Complex Formulations",
    "sector_kpis": {
      "kpi_1": "US Formulation Sales: $517 Million (Q2 FY25)",
      "kpi_2": "EBITDA Margin: 29.6% (Q2 FY25)",
      "kpi_3": "R&D Spend: 6.0% of Sales (Q2 FY25)"
    },
    "moat_rating": "Wide",
    "competitive_position": "LEADER"
  },
  "_cached_at": "2025-12-24T22:16:41.717379",
  "_symbol": "SUNPHARMA"
}